Trogarzo
Chemical Name | ibalizumab-uiyk |
Dosage Form | Injectable (intravenous; 150 mg/mL) |
Drug Class | Monoclonal antibodies |
System | Blood |
Company | Taimed Biologics USA |
Approval Year | 2018 |
Indication
- Trogarzo in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection failing their current antiretroviral regimen.